Drugs / ELB139
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00322803 | May → Oct 2006 | panic disorder | elbion AG | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ELB139 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00322803 ↗ |
| Route | Oral | “ELB139 given orally” NCT00322803 ↗ |